Clindamycin: uses, dosing, side effects & brands

Clindamycin phosphate, a lincosamide, is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin.

The FDA classifies clindamycin as a lincosamide antibacterial. Lincosamides such as clindamycin attach to the bacterial ribosome, the cell's protein-building machine, and stop it from linking amino acids together. Because the bacteria can no longer make the proteins they need, their growth is halted or, depending on the organism and dose, they are killed. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

The elimination half-life of clindamycin is about 2.4 hours — that is how long the body takes to clear half of a dose. The label gives an average biological (elimination) half-life of 2.4 hours for oral clindamycin hydrochloride, the active form. It runs slightly longer in older adults (about 4.0 hours, range 3.4–5.1, vs 3.2 hours, range 2.1–4.2, in younger adults) and is increased slightly in people with markedly reduced kidney or liver function. Clindamycin palmitate (oral pediatric solution) and clindamycin phosphate (injection) are inactive prodrugs that are hydrolyzed in the body to this same active clindamycin. Half-life reflects how fast the drug leaves the blood, not how long a drug test can detect it. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run clindamycin against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

We track 11 clindamycin-containing products in the U.S.: Clindesse, Xaciato, Cleocin, Cleocin Hydrochloride, Cleocin Phosphate in Dextrose 5% in Plastic Container, Cleocin T, Cleocin Phosphate and Clindagel, and 3 more. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

Across the brands we track, clindamycin is currently marketed as topical, suppository, capsule, injectable and spray/inhaler, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Yes. Our catalog lists 2 generic clindamycin products alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

The FDA's Enforcement database lists at least 5 recall records whose product description mentions clindamycin. The most recent: CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION (Jul 30, 2026). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

The most frequently reported effects are gastrointestinal: diarrhea, nausea, vomiting, and stomach pain, along with an unpleasant or metallic taste in the mouth. MedlinePlus also lists joint pain, and — with the vaginal form — vaginal burning, itching, or a thick white discharge. Many mild cases ease as your body adjusts, but any diarrhea deserves attention with this drug (see below). This is not a complete list; ask your pharmacist about effects specific to your dose and formulation.

The defining serious risk of clindamycin is Clostridioides difficile (C. difficile)-associated diarrhea and colitis — a bacterial overgrowth in the colon that can be life-threatening. Call your doctor right away if you have, in MedlinePlus's words, "watery or bloody stools, diarrhea, stomach cramps, or fever," which "may cause a life-threatening condition called colitis (inflammation of the large intestine)." Also seek urgent care for signs of a severe allergic or skin reaction: "rash, hives, itching, peeling or blistering skin; hoarseness, difficulty breathing or swallowing, or swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs," or yellowing of the skin/eyes or decreased urination. Do not take any anti-diarrhea medicine to manage this diarrhea without asking your doctor first — it can trap the toxin and make colitis worse.

Yes — this is the point most people miss. The C. difficile diarrhea/colitis can begin during treatment or long after you stop. MedlinePlus warns it can happen "during your treatment with clindamycin or during the first several months after your treatment has finished," and the FDA labeling notes CDAD has been reported to occur even more than two months after the antibiotic. So a new episode of severe or bloody diarrhea, cramping, or fever after your course ends is not a stomach bug to ignore — tell your doctor and mention you recently took clindamycin.

Nausea, taste changes, and stomach upset tend to appear within the first days of dosing. Diarrhea can start at any point during treatment or, as above, weeks to months afterward. Finish the entire prescription even once you feel better: MedlinePlus notes that if you "stop taking clindamycin too soon or skip doses, your infection may not be completely treated" and bacteria can become resistant. Never stop or change an antibiotic on your own — call your prescriber if side effects are making it hard to continue.